These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17717947)

  • 21. Comparing the new antihistamines: the role of pharmacological parameters.
    Devillier P
    Clin Exp Allergy; 2006 Jan; 36(1):5-7. PubMed ID: 16393259
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction: anti-IgE.
    Bochner B; Saini S
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):1-2. PubMed ID: 16222079
    [No Abstract]   [Full Text] [Related]  

  • 23. [Allergic rhinoconjunctivitis and immunotherapy: an update].
    Leimgruber A; Spertini F
    Rev Med Suisse; 2009 Jan; 5(186):88-93. PubMed ID: 19238924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of various allergic diseases in children with histaglobin].
    Lokotkina EA; Iakobson MI; Lukash NI; Ivanova EI; Popova RP
    Vopr Okhr Materin Det; 1972 Apr; 17(4):91-2. PubMed ID: 4404217
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduction of the total IgE level by omalizumab in children and adolescents.
    Steiss JO; Strohner P; Zimmer KP; Lindemann H
    J Asthma; 2008 Apr; 45(3):233-6. PubMed ID: 18415832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs allergic disorders.
    Treat Guidel Med Lett; 2013 May; 11(129):43-52. PubMed ID: 23628849
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of solar urticaria with anti-immunoglobulin E therapy.
    Güzelbey O; Ardelean E; Magerl M; Zuberbier T; Maurer M; Metz M
    Allergy; 2008 Nov; 63(11):1563-5. PubMed ID: 18925897
    [No Abstract]   [Full Text] [Related]  

  • 28. Effective therapies for managing seasonal allergic rhinitis.
    Cross S
    Community Nurse; 2000 Apr; 6(3):17-8. PubMed ID: 12778501
    [No Abstract]   [Full Text] [Related]  

  • 29. Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma.
    Humbert M; Berger W; Rapatz G; Turk F
    Allergy; 2008 May; 63(5):592-6. PubMed ID: 18355388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The newer anti-allergic agents.
    Wilhelm RE
    Trans Indiana Acad Ophthalmol Otolaryngol; 1967 May; 50():53-72. PubMed ID: 4194663
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of allergy to mould spores].
    Jahnz-Rózyk K; Bogacka E
    Pol Merkur Lekarski; 2003 May; 14(83):385-7. PubMed ID: 12939808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
    Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
    Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antihistamine drugs in the treatment of allergic skin diseases].
    Kaszuba A
    Pol Merkur Lekarski; 2003 Jun; 14(84):640-6. PubMed ID: 14524291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-histamines].
    Bonneau JC; Drouet M; Sabbah A
    Allerg Immunol (Paris); 1999 Apr; 31(4):106-8. PubMed ID: 10370722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. News advance in allergy immunotherapy.
    Mayo Clin Health Lett; 2008 May; 26(5):4. PubMed ID: 18595155
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic possibilities and clinical effects of IgE level modulation in allergic diseases].
    Bobrowska M; Stelmach I
    Pneumonol Alergol Pol; 2004; 72(1-2):70-4. PubMed ID: 15757296
    [No Abstract]   [Full Text] [Related]  

  • 37. Asthma treatment: 'magic bullets which seek their own targets'.
    Tarantini F; Baiardini I; Passalacqua G; Braido F; Canonica GW
    Allergy; 2007 Jun; 62(6):605-10. PubMed ID: 17508963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future forms of immunotherapy and immunomodulators in allergic disease.
    Nguyen TH; Stokes JR; Casale TB
    Immunol Allergy Clin North Am; 2011 May; 31(2):343-65, x-xi. PubMed ID: 21530824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD; Turk F
    Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug treatment in allergic disorders.
    Dolowitz DA
    Otolaryngol Clin North Am; 1971 Oct; 4(3):591-8. PubMed ID: 4106824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.